Social dialogue quality and workers’ health as perceived by Belgian trade union representatives during the COVID-19 pandemic

Jacques Wels; Natasia Hamarat; Vanessa De Greef

doi:10.1101/2023.04.10.23288317

Abstract

Background Besides major employment disruptions, the COVID-19 pandemic has generated policy responses with specific mechanisms to protect workers’ health. In Belgium, most of these policies were negotiated at national and cross-sectorial level but implemented at company level with company-based collective negotiation playing a key role. This study examines the relationship between trade union representatives’ perception of social dialogue quality and change in workers’ physical and mental health in such a context.

Methods Union representatives were surveyed throughout Belgium between August and December 2021 through an online questionnaire (N=469). We asked about the way they perceived workers’ physical and mental health within their companies and explain variations with the self-perceived change in quality of social dialogue as an exposure. We use a modified Poisson regression for binary outcomes on four stratified models that additively account for no control, company characteristics, pre-pandemic self-reported health and COVID-19-related measures. Weights are generated to ensure sector representativeness.

Results 30.1% of the sample reported a worsening social dialogue quality during the pandemic. Relative Risks (RR) of poor physical and mental health when social dialogue has worsened are respectively 1.49 [95%CI:1.03; 2.15] and 1.38 [95%CI= 1.09;1.74] when controlling for company characteristics and pre-pandemic health. Adding pandemic-related measures reduces the risk of both poor mental [RR=1.25; 95%CI: 0.84; 1.87] and physical health [RR=1.18; 95%CI:0.94;1.49].

Conclusions Although based on self-reported variables, the study shows an association between poor social dialogue quality and poor physical and mental health during the COVID-19 pandemic that must be explored further in post-pandemic context.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No specific funding was allocated for this research. JW is funded by the FNRS (Fonds National pour la Recherche Scientifique) research associate fellow grant (CQ) number 40010931.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study received an ethic approval given by the Ethic Committee of the Faculty of Philosophy and Social Sciences (Universite libre de Bruxelles) given on the 11th of January 2021.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The dataset cannot be openly shared due to the collection of sensitive individual data and sample size. Specific data access on a restricted number of items can be formally requested to the authors.